Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04181970 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Observational Study, for Quality Assessment, of Sarcoma in European and Latin American Multidisciplinary NETWORK

Study acronym: (SELNET)
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated March 21, 2025 (before its estimated September 30, 2026 completion). Its status may not reflect the trial's current state.

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion date: Sep 30, 2024 to Sep 30, 2026
    • Study completion date: Sep 30, 2025 to Sep 30, 2026
    • Site details revised at 1 of 9 sites
    v5
  2. Primary completion date: Jun 30, 2023 to Sep 30, 2024
    • Study completion date: Sep 30, 2023 to Sep 30, 2025
    v4
  3. Primary completion date: Jan 30, 2022 to Jun 30, 2023
    • Study completion date: Jan 30, 2023 to Sep 30, 2023
    • Eligibility criteria revised
    • Study sites revised (9)
    v3
  4. Re-verified, no change to tracked fieldsv2
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Post-authorisation, multicentric, observational, retrospective and prospective study to assess quality of care of sarcoma patients in expert and non-expert centers by analysing correlation of quality items and outcomes such as relapse free survival, overall survival, percentage of amputation, etc. Expert pathology peer review will be performed to detect differences between expert and non-expert centers as well as differences in treatment and patient prognosis. Tumor samples of 4 types of sarcoma would also be included in translational research to detect biomarkers and produce preclinical models.
Trial Details
NCT Number NCT04181970
Lead Sponsor Grupo Espanol de Investigacion en Sarcomas
Conditions
(from sponsor)		 Soft-tissue Sarcoma, Gastrointestinal Stromal Tumors, Bone Sarcoma
Related terms Bone Neoplasms, Gastrointestinal Stromal Tumors, Sarcoma
Enrollment 5,000 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov